Celldex Therapeutics | CLDX - Bienes





Bienes Cambio Fecha
AbbVie USD 133.96B 62M 2025-12
Agenus USD 233.89M 48.67M 2025-09
Amgen USD 90.59B 445M 2025-12
Bristol-Myers Squibb USD 96.89B 2.21B 2025-09
Celldex Therapeutics USD 582.98M 65.46M 2025-12
Glaxosmithkline GBP 82.45B 23.19B 2025-09
Nektar Therapeutics USD 301.35M 93.81M 2025-09
Northwest Biotherapeutics USD 30.61M 1.06M 2025-09
Pfizer USD 208.73B 2.64B 2025-09
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12